Associate Editor for Contemporary OB/GYN. You can reach her a lcarr@mjhlifesciences.com.
Live Webinar: Race for a COVID-19 vaccine
July 28th 2020This Thursday, July 30, 2020 at 6 p.m. EDT, join us for a 1-hour live webinar as experts in infectious disease, virology, and vaccinology break down the top vaccine candidates, key findings from the latest clinical trials, and discuss ways to overcome the logistical hurdles of a vaccine rollout amid a global pandemic.
Read More
Video: Racial justice and health equity in healthcare with Dr. Washington Hill
July 21st 2020Contemporary OB/GYN Senior Editor Angie DeRosa interviews Maternal-Fetal Medicine Specialist Dr. Washington Hill to get his perspective on what practicing ob/gyns can do to address implicit bias and racism in the health care system.
Read More
Women living with HIV and persistent levels of depression may be at higher risk of heart disease
July 17th 2020A new study, published in the Journal of the American Heart Association, examined the reasons for which women with HIV (WLWH) tend to have increased risk of plaque buildup in their arteries (atherosclerotic).
Read More
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Read More
Pap Talk S1E2: Dr. Dotters-Katz, Duke Health on COVID-19, pandemic jam and more
July 15th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Sarah Dotters-Katz, a Maternal-Fetal Medicine Specialist at Duke Health in Durham, NC, in which she discusses her perspective on COVID-19 and its impact on pregnant patients in her area of the US.
Read More
Aromatase inhibitors for climacteric symptoms in women with breast cancer
July 8th 2020New research shows that, in postmenopausal women undergoing hormone therapy for breast cancer, aromatase inhibitors (AIs) lead to a reduction in climacteric symptoms and significantly improved quality of life.
Read More